If you're living with IgA nephropathy (IgAN), you know the weight it carries—the constant worry about your kidneys, the fatigue from proteinuria, and the fear of progressing to dialysis or a ...

Gilead Sciences has found a shiny new package for one of its cancer assets, inking a research pact worth up to $300 million ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

A commonly discussed concept in CitrusBurn reviews and consumer feedback is the idea of "clean energy.” This term is often ...

An informational consumer evaluation guide to best blood sugar supplement criteria for 2026, Akkermansia muciniphila and ...

Here, BioSpace looks back at the biggest acquisition deals of 2025. Target: Intra-Cellular Therapies Acquisition date: ...

Traumatic experiences during infancy and childhood can leave a lasting imprint on an individual’s health. New research ...

An evidence-based exploration of how culinary botanicals synergize with cannabinoids to create pharmacologically active, ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...

Chemists from the National University of Singapore (NUS) have developed a single-atom photocatalytic strategy that enables ...

The US FDA approved 46 new drugs in 2025, despite a tumultuous year at the regulatory agency.

Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...